Loading...
XWAR
KCH
Market cap892kUSD
Jul 09, Last price  
0.38PLN
1D
29.31%
1Q
-7.64%
Jan 2017
-86.93%
IPO
-93.91%
Name

Krakchemia SA

Chart & Performance

D1W1MN
XWAR:KCH chart
P/E
—
P/S
0.13
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
-25.58%
Revenues
25m
-43.75%
279,331,000313,540,000252,760,000390,441,000499,413,000535,663,000583,091,000592,635,000535,391,000447,045,000277,960,000225,576,000182,408,000109,935,000114,117,00093,503,00080,163,00044,599,00025,088,000
Net income
-12m
L-10.11%
2,819,0002,504,0002,170,0005,118,0006,959,00010,238,0009,007,0003,536,0007,299,000-9,686,000-8,367,000-12,861,000-13,009,000-5,781,000288,000-10,837,000-68,261,000-13,493,000-12,129,000
CFO
-1m
L+429.06%
-22,308,000-2,403,0008,196,000-8,446,0005,986,000-3,509,00015,126,000-245,00023,959,00017,839,0008,476,000-840,000-1,269,0003,196,0001,829,000-1,568,000801,000-265,000-1,402,000
Dividend
Jul 15, 20140.6 PLN/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Krakchemia S.A. functions as a wholesale distributor of chemical products, serving markets across Poland and internationally. The company offers a diverse range of plastic raw materials, which includes polyethylene, polypropylene, styrene fibers, plastics for construction, mineral fillers, masterbatches, and various processing aids. Additionally, its product portfolio extends to packaging films. Beyond plastics, Krakchemia supplies general chemical materials, specific chemical reagents, and a variety of laboratory essentials such as filters, testing standards, chemical testing kits, laboratory glassware, and advanced HPLC, GC, and UPLC chromatographic columns. An online store further supports its sales operations. Established in 1945 and based in Kraków, Poland, the company was formerly known as KrakChemia – Hurt S.A. before officially adopting its current name in November 2004.
URL
https://www.krakchemia.com.pl/
IPO date
Aug 23, 2007
Employees
37
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT